ArticleVox sanguinis2026
A quality improvement initiative to reduce inappropriate plasma transfusions across community hospitals in the Niagara region.
Article in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesPlasma transfusion is indicated for patients with coagulopathy and active bleeding or those undergoing major surgery. Appropriate use is defined by an international normalized ratio (INR) >1.7 and a dose of 3-4 units for adults. However, audits in tertiary care settings consistently revealed high rates of inappropriate plasma use. At Niagara Health, audits across three community hospitals showed that 42% of plasma transfusions in hospitalized adults were inappropriate, largely due to limited understanding of proper indications. This misuse leads to resource wastage, higher costs and unnecessary patient exposure to transfusion-related risks. The aim of this project was to improve appropriate plasma transfusion rates among hospitalized adults in three Niagara region hospitals by 25% over a 12-month period. MATERIALS AND
methodsThis non-randomized, interrupted time series quality improvement project followed the Model for Improvement (MFI) framework. Sequential Plan-Do-Study-Act cycles began in July 2024, with monthly monitoring of transfusion rates. Interventions included an awareness campaign, enhanced audit and feedback and implementation of an electronic transfusion order set in the electronic medical record (EMR).
resultsDuring the study, 253 plasma units were transfused. Median monthly appropriateness rates were 90% (INR >1.7), 89% (dose >2 units) and 78% (both criteria). Appropriateness improved, particularly in dosing. Out-of-guideline requests screened by technologists decreased by 15%, with no significant change in plasma or red cell use.
conclusionElectronic order sets, technologist screening, education and audit-feedback improved adherence to plasma transfusion guidelines without increasing workload or affecting other blood product use. These strategies may be scalable to other components.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.